Location: Home
  • search
  • go
  • Relate News
  • 3/2/2022FDA OKs J&J and Legend's BCMA CAR-T, Setting Stage for Showdown with B...
  • 3/1/2022Financial-related Company News Digest
  • 3/1/2022Digestome Therapeutics Licenses Schizophrenia Drug DGX-001 for Greater...
  • 2/28/2022Most MNCs and Domestics Face Serious Headwinds, But Some Managed to Ex...
  • 2/26/2022IQVIA: Chinese Hospital Drug Market Rose 2.2% in MAT Q4/2021
  • 2/23/2022Kiniksa Pharma and Huadong Medicine Announce Strategic Collaboration
  • 2/22/2022Stemirna gets ready for China's own mRNA Covid-19 vaccine as global mu...
  • 2/22/2022Eli Lilly Fared Well in China Last Year Despite Slowing Q4 Growth over...
  • 2/21/2022245 Listed MedPharm Cos Release 2021 Performance Guidance and Results ...
  • 2/21/2022Inter-Provincial Pacts on Bulk-Buying Drugs Are on the Rise in China, ...
  • 2/21/2022Cross-border Medical Data Compliance in New Era of Regulation
  • 2/18/2022Recent Executive Moves
  • 2/17/2022Innovent Ready to Challenge Amgen and Sanofi in PCSK9 Inhibitor Market...
  • 2/17/2022Review of Chinese Pharma Deals, R&D and Regulatory Developments in 202...
  • 2/17/2022Chinese Pharmaceutical Cross-Border M&A in 2022 (PharmExec)
  • 2/16/2022SciNeuro and Alamar Collaborate to Discover Novel Therapeutic Antibodi...
  • 2/16/2022Organon Acquires Bayer's Contraceptive Products Marvelon and Mercilo...
  • 2/16/2022Information Collection on the 7th VBP Officially Initiated by the JPO
  • 2/15/2022Snapshot of MNC Pharma's China Performance in 2021
  • 2/15/2022Moderna Announces Plan to Expand Footprint in Asia with Four Additiona...
  • 2/15/2022ChinaBio Partnering Forum Acquired by EBD Group/Informa
  • 2/14/2022Chinese CDMO Asymchem to Expand in the U.S. thru Acquisition of Snapdr...
  • 2/14/2022Chinese Drug Developers Look to Enter the U.S. Market through Out-lice...
  • 2/13/2022Innovent's Setback Warns Peers Prioritizing Pricing Not Good Tactic in...
  • 2/13/2022State Council's Policy Briefing Confirms Accelerated Expansion of Cent...
  • 2/10/2022AstraZeneca Reports Q4 and FY 2021 Performance, China Revenue Surging ...
  • 2/10/2022GSK Won Chinese Approval of Benlysta (belimumab) for Adult Patients wi...
  • 2/10/2022U.S. FDA Panel Recommends Additional Trial for Lilly/Innovent Lung Ca...
  • 2/10/2022CDE issues the Technical Guidelines for Clinical Pharmacology Study of...
  • 2/10/2022Why the FDA Is Making a Test Case of a Cancer Drug from China
  • Page:48/333 Total number of articles:9989: [First][<<] [46] [47] [48] [49] [50] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group